PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-06-29

Date Title Company
29-Jun-2021 Half of European and US Pharma Manufacturers Believe AI Can Help Bring New Drugs to Market Quicker Aspen Technology
29-Jun-2021 Dxcover Limited appoints Operations Director as it targets further growth Dxcover Limited
29-Jun-2021 2021 pharmaceutical industry Code of Practice launched Association of the British Pharmaceutical Industry (ABPI)
29-Jun-2021 WORLD-CLASS ADULT AND NEONATAL INTENSIVE CARE UNITS OPEN AT CHELSEA AND WESTMINSTER HOSPITAL Chelsea and Westminster Hospital NHS Foundation Trust
29-Jun-2021 Single-dose Sputnik Light vaccine registered in Kyrgyzstan Russian Direct Investment Fund
29-Jun-2021 Lilly’s SURPASS-2 results published in The New England Journal of Medicine show tirzepatide achieved superior HbA1C and body weight reductions compared to injectable semaglutide in adults with type 2 diabetes Eli Lilly and Company
29-Jun-2021 Test batch of the Sputnik V vaccine produced in Iran Russian Direct Investment Fund
29-Jun-2021 Investigational 2.0 mg dose of Ozempic® (semaglutide) demonstrates superior reductions in blood sugar vs Ozempic® 1.0 mg in adults with type 2 diabetes in a phase 3 trial Novo Nordisk
29-Jun-2021 Idorsia initiates the Phase 3 registration study with selatogrel for the treatment of acute myocardial infarction Idorsia
29-Jun-2021 Dupixent® (dupilumab) SmPC updated with long-term data reinforcing well-established safety profile in adults with moderate-to-severe atopic dermatitis Sanofi
29-Jun-2021 First Head & Neck Cancer Patient Enrolled in the UK in a Phase I Trial with TG4050 (myvac® Platform), Transgene’s Innovative Individualized Immunotherapy Transgene
29-Jun-2021 Nirsevimab shows positive topline results in RSV Phase 2/3 MEDLEY trial Sanofi
29-Jun-2021 GB Sciences Using AI Technology in Plant-Based Drug Discovery Research Newswire
29-Jun-2021 BioConnection receives from the Dutch Healthcare Inspectorate (IGJ) the GMP certification and manufacturing license for their new large scale filling line BioConnection B.V.
29-Jun-2021 Forxiga recommended for approval in the EU by CHMP for the treatment of patients with chronic kidney disease AstraZeneca
29-Jun-2021 GENTRONIX COMPLETES ACQUISITION OF BIG BLUE® TRANSGENIC MUTATION ASSAY MODELS Gentronix
29-Jun-2021 Doctor Care Anywhere launches mental health proposition Doctor Care Anywhere
29-Jun-2021 Vertex Announces New Portfolio Reimbursement Agreement in Italy Including KAFTRIO®, SYMKEVI® and Additional Indications of ORKAMBI® and KALYDECO® for Eligible Patients With Cystic Fibrosis Vertex
29-Jun-2021 Vertex Announces National Reimbursement Agreement in France for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) and SYMKEVI® (tezacaftor/ivacaftor) for Eligible Cystic Fibrosis Patients Vertex
29-Jun-2021 Sputnik V has demonstrated 97.8% efficacy against COVID cases and 100% efficacy against severe cases of COVID in UAE Russian Direct Investment Fund